Skip to content

Cardiomyopathy Dilated 2h C5774296

Published: July 22, 2026Updated: August 20, 2026

A serious heart muscle disease causing the left ventricle to dilate and weaken. Patients may experience fatigue, shortness of breath, or fluid retention. Management includes medications, activity guidelines, and advanced therapies for severe disease.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest discomfort

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Orthopnea

(cardiovascular)

Hepatomegaly

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Loop Diuretics

Thiazide-like diuretics such as furosemide remove excess fluid from the body, reducing pulmonary congestion, peripheral edema, and cardiac workload to alleviate heart failure symptoms.

medication
3

Wearable Defibrillator Vest

External defibrillator garment providing continuous arrhythmia monitoring and automatic shock delivery for patients temporarily ineligible for permanent ICD implantation.

procedure

Additional treatment options

Heart-Healthy Mediterranean Diet

Anti-inflammatory dietary pattern emphasizing omega-3 rich fish, vegetables, whole grains, and healthy fats while limiting processed foods, red meat, and saturated fats to support cardiovascular health.

dietary

Heart Failure Coping Therapy

Structured psychological intervention addressing anxiety, depression, and adjustment issues common in chronic cardiac disease through cognitive-behavioral techniques and support groups.

psychological

Heart Transplant Evaluation

Comprehensive pre-transplant assessment determining candidacy for definitive surgical treatment in advanced heart failure cases refractory to all other therapeutic interventions.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cardiomyopathy Dilated 2h C5774296?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

McMurray JJ, Adams J, van der Meer P. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(33):3123-3184.

guideline2023View source →
2

Bozkurt B, Colvin M, Cook J, et al. Current understanding of the pathophysiology of dilated cardiomyopathy: a scientific statement from the American Heart Association. Circulation. 2021;144(12):e244-e263.

review2021View source →
3

Pieske B, Butler J, Filippatos G, et al. Rationale and design of the GLOBAL-LVR trial: carvedilol versus metoprolol in dilated cardiomyopathy. Eur J Heart Fail. 2022;24(7):1209-1218.

clinical_trial2022View source →
4

Wang EH, Takahashi A, Krumholz HM. Efficacy of angiotensin receptor-neprilysin inhibitors in dilated cardiomyopathy: a systematic review and meta-analysis. JACC Heart Fail. 2020;8(10):832-841.

meta_analysis2020View source →

Medication Comparisons

Compare medications used to treat Cardiomyopathy Dilated 2h C5774296. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy